Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Stellar start to 2025

Newmont Corporation
3:27pm
April 24, 2025
NEM achieved a strong production, cost and cash flow result in the 1Q helped by record high gold prices, which saw it achieve record free cash flow. Net debt reduced by -39% qoq as a result record cash flows and a ~US$1bn debt repayment. NEM has now bought back ~US$755m of its shares since the start of CY25 and expects to continue to do so for the remainder of this year and into CY26. We Maintain our ADD rating with a A$97ps TP (previously A$84ps).

Model update: Q1 traffic and toll revenue, FX rates

Atlas Arteria
3:27pm
April 23, 2025
We update our forecasts to reflect 1Q25 traffic and toll revenue data released by ALX. In addition, we update the AUDEUR and AUDUSD rates used in our modelling, with the decline in the spot AUDEUR particularly beneficial for ALX. Our modelling indicates ALX will have sufficient distributable cashflow and cash reserves to support at least 40 cps of annual DPS until at least the end of the decade. At current prices, this implies a cash yield of 8.1%. 12 month target price lifts 49 cps to $5.09/sh. Total potential 12 month return at current prices is c.11% (or c.4% ex IFM takeover potential). Assuming no corporate activity and given the APRR’s decaying equity value we estimate a 5 year investment IRR at current prices of c.7.0% pa. HOLD retained.

Spring in the step

Imricor Medical Systems
3:27pm
April 23, 2025
IMR has made an exciting start to CY25 which included a major step forward in interventional medicine with the first-in-human ventricular ablation procedure guided by real time MRI. IMR finished 1Q25 in a strong cash position following a A$70m capital raising. Cash receipts remain modest, however subsequent quarters are expected to see growth with the sales teams being strengthened and approvals secured for its 2nd generation Catheter in Europe. Upcoming catalysts include additional sales, clinical trial updates and approvals. We have made no changes to forecasts or valuation. We maintain our Speculative Buy recommendation.

International spotlight

LVMH
3:27pm
April 23, 2025
LVMH Louis Vuitton Moët Hennessy SE is a multinational luxury group conglomerate based in Paris, France. It operates five business segments: Wines and Spirits; Fashion and Leather Goods; Perfume and Cosmetics; Watches & Jewelry; and Selective Retailing. Its 75 brands include Dom Pérignon, Moët & Chandon, Veuve Clicquot, Hennessy, Louis Vuitton, Christian Dior, Givenchy, Acqua di Parma, Tiffany & Co, TAG Heuer, Bulgari, DFS, and Sephora. LVMH operates over 5,600 stores worldwide. LVMH was formed by Bernard Arnault, Alain Chevalier and Henry Racamier in 1987 from the merger of Louis Vuitton and Moët Hennessy. Louis Vuitton itself was founded as a manufacturer of luggage in 1854. Moët Hennessy was formed in 1971 through the merger of the champagne house Moët & Chandon (founded 1743) and the cognac producer Hennessy (founded 1765). Some of LVMH’s more recent acquisitions include Tiffany & Co. in 2020, Rimowa in 2016 and Loro Piana in 2013.

Not now, but soon

Proteomics International Laboratories
3:27pm
April 23, 2025
PIQ has completed a A$4.5m placement to fund the commercial launch across its range of diagnostic tests in Australia and the US as well as upgrading systems and establishing laboratory platforms. The placement coincides with an SPP, aiming to raise a further A$1m. The placement addresses immediate cash concerns, although it appears insufficient to see the company through to meaningful commercial success. We believe that the in-house commercial rollout and reliance on out-of-pocket funding will hinder initial sales and thereby extend the timeframe to achieve meaningful revenues. Notwithstanding our longer-term view that there is substantial value in these tests, we view there is commercial risk, time, expenses, and likely another capital injection to wash through before the sales traction gets interesting. Happy to hold at these levels or add small positions on weakness for risk tolerant investors. Following our changes, our target price is reduced to A$0.43 p/s but we retain our Hold recommendation.

Steadies the ship, builds cash

South32
3:27pm
April 22, 2025
Solid quarter operationally, aside from Cannington’s downgrade, which was not altogether shocking from the aging mine. Net cash of US$252m highlights a strong capital position and solid resilience. Hermosa build and GEMCO restart are key growth levels, with broader portfolio largely in harvest mode – leaving South32 share price sensitive to metal prices. Maintain ADD rating with unchanged A$4.30 target price.

Key name if you are considering a flight-to-quality

BHP Group
3:27pm
April 17, 2025
Strong 3Q25 operational performance was driven by a significant copper beat and resilient WAIO shipments despite cyclone impacts. A major medium-term guidance upgrade for Escondida copper (FY27-FY31) removed a previously anticipated production dip, a significant positive. BMA coal faced headwinds from severe weather and operational issues, leading to a production miss and an increase in FY25 unit cost guidance. Achieved its gender balance target with female participation hitting 40% - another positive competitive differentiator. BHP continues to hold the mantle for best-in-class, with strong earnings quality, return profile and balance sheet. We maintain an ADD rating with A$48.70 TP.

3Q25 traffic, implications of recent bond issuance

Transurban Group
3:27pm
April 17, 2025
We revise our forecasts to reflect 3Q25 traffic data and recent debt issuance in the Eurobond market. FY25F Free Cash is upgraded by 1% and downgraded 1-2% in FY26-27F. HOLD retained, given at current prices we estimate a 12 month potential return of -4% (including 4.7% cash yield) and 5 year investment IRR of <5% pa.

In a superior position to peers

Pilbara Minerals
3:27pm
April 17, 2025
3Q25 was impacted by ramp-up and tie-in activities. FY25 guidance maintained. P1000 ramp-up tracking to plan and improvements expected in June-Q’25. Maintain ADD rating with a A$2.30ps TP (previously A$2.40ps).

Dominated by oil malaise

Karoon Energy
3:27pm
April 17, 2025
A solid 1Q25 result given the planned (and flagged) maintenance shutdown at Karoon’s flagship Bauna operation, with 1Q25 marginally ahead of expectations. The Bauna FPSO reached 92.3% uptime in the quarter, excluding the shutdown, compared to 84.6% in the prior quarter. Karoon is moving Neon into a define phase, increasing FY25 capex by ~6%. All production and cost guidance has been maintained. Maintain ADD rating with a lower A$2.25ps target price (was A$2.40).

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more